Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0060 Transporter Info | ||||
Gene Name | ABCC7 | ||||
Transporter Name | Cystic fibrosis transmembrane conductance regulator | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
ATF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in pancreatic cancer condition | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-1 | Transcription Factor Info | ||||
Studied Phenotype |
Pancreatic cancer [ICD11: 2C10] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human pancreatic ductal adenocarcinoma cells (Panc-1) | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-1 (ATF1) has been reported to activate the transcription of CFTR gene in pancreatic cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in health condition | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human bronchus epithelial cells (BEAS-2B) | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) has been reported to activate the transcription of CFTR gene in health condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
NFE2L2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CFTR gene in cystic fibrosis condition | [3] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human bronchus epithelial cells (BEAS-2B) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to repress the transcription of CFTR gene in cystic fibrosis condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in colon cancer condition | [4] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to activate the transcription of CFTR gene in colon cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in health condition | [2] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human bronchus epithelial cells (BEAS-2B) | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) has been reported to activate the transcription of CFTR gene in health condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
mutated TFAP2A (Y1424A) |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CFTR gene in cystic fibrosis condition | [5] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human lung adenocarcinoma cells (Calu-3) | |||||
Detailed Description |
mutated Transcription factor AP-2-alpha (mutated TFAP2A (Y1424A)) has been reported to repress the transcription of CFTR gene in cystic fibrosis condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NR1I3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC7 gene in health condition | [6] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 3 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 3 (NR1I3) has been reported to activate the transcription of ABCC7 gene in health condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
SP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CFTR gene in cystic fibrosis condition | [7] | ||||
TF Protein Name |
Transcription factor Sp3 | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human lung adenocarcinoma cells (A549) | |||||
Detailed Description |
Transcription factor Sp1 (SP1) has been reported to repress the transcription of CFTR gene in cystic fibrosis condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
SP3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in cystic fibrosis condition | [7] | ||||
TF Protein Name |
Transcription factor Sp3 | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human lung adenocarcinoma cells (A549) | |||||
Detailed Description |
Transcription factor Sp3 (SP3) has been reported to activate the transcription of CFTR gene in cystic fibrosis condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
YY1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in cervical cancer condition | [8] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Studied Phenotype |
Cervical cancer [ICD11: 2C77] | |||||
Tissue |
Cervix | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa) | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) has been reported to activate the transcription of CFTR gene in cervical cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Transcriptional Phenomenon 2 |
Repression of CFTR gene in cystic fibrosis condition | [3] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human bronchus epithelial cells (BEAS-2B) | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) has been reported to repress the transcription of CFTR gene in cystic fibrosis condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Transcriptional Phenomenon 3 |
Repression of CFTR gene in health condition | [2] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human bronchus epithelial cells (BEAS-2B) | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) has been reported to repress the transcription of CFTR gene in health condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CDX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in colon cancer condition | [9] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2) has been reported to activate the transcription of CFTR gene in colon cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
CUX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CFTR gene in pancreatic cancer condition | [1] | ||||
TF Protein Name |
Homeobox protein cut-like 1 | Transcription Factor Info | ||||
Studied Phenotype |
Pancreatic cancer [ICD11: 2C10] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human pancreatic ductal adenocarcinoma cells (Panc-1) | |||||
Detailed Description |
Homeobox protein cut-like 1 (CUX1) has been reported to repress the transcription of CFTR gene in pancreatic cancer condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in colon cancer condition | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of CFTR gene in colon cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in colon cancer condition | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to activate the transcription of CFTR gene in colon cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in colon cancer condition | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to activate the transcription of CFTR gene in colon cancer condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
FOXI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CFTR gene in obstructive azoospermia condition | [11] | ||||
TF Protein Name |
Forkhead box protein I1 | Transcription Factor Info | ||||
Studied Phenotype |
Obstructive azoospermia [ICD11: GB04.0] | |||||
Tissue |
Fetal vas deferens | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human fetal vas deferens epitheliums(HVP) | |||||
Detailed Description |
Forkhead box protein I1 (FOXI1) has been reported to repress the transcription of CFTR gene in obstructive azoospermia condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SRF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in cystic fibrosis condition | [12] | ||||
TF Protein Name |
Serum response factor | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human bronchus epithelial cells (BEAS-2B) | |||||
Detailed Description |
Serum response factor (SRF) has been reported to activate the transcription of CFTR gene in cystic fibrosis condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 6.1: Rel homology region factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NFKB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in lung adenocarcinoma condition | [13] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Studied Phenotype |
Lung adenocarcinoma [ICD11: 2C25.0] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human lung adenocarcinoma cells (Calu-3) | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to activate the transcription of CFTR gene in lung adenocarcinoma condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CFTR gene in lung adenocarcinoma condition | [13] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
Lung adenocarcinoma [ICD11: 2C25.0] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human lung adenocarcinoma cells (Calu-3) | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of CFTR gene in lung adenocarcinoma condition, which leads to an increased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
Class 6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CFTR gene in cystic fibrosis condition | [14] | ||||
TF Protein Name |
Signal transducer and activator of transcription 1-alpha/beta | Transcription Factor Info | ||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | |||||
Tissue |
Bronchus | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human bronchus epithelial cells (16HBE14o-) | |||||
Detailed Description |
Signal transducer and activator of transcription 1-alpha/beta (STAT1) has been reported to repress the transcription of CFTR gene in cystic fibrosis condition, which leads to a decreased expression of the drug transporter Cystic fibrosis transmembrane conductance regulator. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.